| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/18/2007 | WO2007006152A1 Compositions from buckwheat for management of diabetes |
| 01/18/2007 | WO2007006143A1 Compositions and methods for detecting transformed cells |
| 01/18/2007 | WO2007006135A1 Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells |
| 01/18/2007 | WO2007006117A1 Novel cyp2a6 inhibitors |
| 01/18/2007 | WO2006130726A3 Use of ladostigil for the treatment of multiple sclerosis |
| 01/18/2007 | WO2006130707A3 Mao-b inhibitors useful for treating obesity |
| 01/18/2007 | WO2006130567A3 Use of carbohydrate-rich compositions to diminish depressive disorders and symptoms thereof |
| 01/18/2007 | WO2006130500A3 Tigecycline and methods of preparing 9-aminominocycline |
| 01/18/2007 | WO2006128120A3 Novel lapachone compounds and methods of use thereof |
| 01/18/2007 | WO2006128032A3 Compositions and methods for the prevention and treatment of conditions associated with inflammation |
| 01/18/2007 | WO2006127941A3 Amorphous cinacalcet hydrochloride and preparation thereof |
| 01/18/2007 | WO2006127926A3 Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts |
| 01/18/2007 | WO2006126081A3 Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors |
| 01/18/2007 | WO2006125914A3 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
| 01/18/2007 | WO2006124875A3 Diarylsulfone sulfonamides and use therof |
| 01/18/2007 | WO2006124720B1 Multidrug resistant anticancer anthracyclines |
| 01/18/2007 | WO2006124713A3 4-biarylyl-1-phenylazetidin-2-ones |
| 01/18/2007 | WO2006124689A3 Combination therapy |
| 01/18/2007 | WO2006124581A3 Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (fsh-r) antagonists |
| 01/18/2007 | WO2006123248A3 Improved methods and devices for delivering a therapeutic product to the ocular sphere of a subject |
| 01/18/2007 | WO2006123207A3 A kit for inhibiting gastric acid secretion having an adjustable amount of ph regulating agent |
| 01/18/2007 | WO2006122977A3 PROCESS FOR PREPARING 3α(β)-7α(β)-DIHYDROXY-6α(β)-ALKYL-5β-CHOLANIC ACID |
| 01/18/2007 | WO2006122299A3 Fish oil in stabilized form |
| 01/18/2007 | WO2006122117A3 Organometal benzenephosphonate coupling agents |
| 01/18/2007 | WO2006122022A3 Modified release famciclovir pharmaceutical compositions |
| 01/18/2007 | WO2006121822B1 USE OF β-LACTAMS FOR THE TREATMENTOF IBD AND GLAUCOMA |
| 01/18/2007 | WO2006120552A3 ANHYDROUS CRYSTALLINE FORMS OF N-[1-(2-ETHOXYETHYL)-5-(N-ETHYL-N-METHYLAMINO)-7-(4-METHYLPYRIDIN-2-yl-AMINO)-1H-PYRAZOLO[4,3-d]PYRIMIDINE-3-CARBONYL]METHANESULFONAMIDE |
| 01/18/2007 | WO2006120010A3 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds |
| 01/18/2007 | WO2006117666A3 Dosage forms, pharmaceutical compositions and methods for sub-tenon delivery |
| 01/18/2007 | WO2006117314A3 Novel piperidin- substituted indoles and their use as ccr-3 modulators |
| 01/18/2007 | WO2006116655A3 Novel isovaleramide forms, compositions thereof, and related methods of use |
| 01/18/2007 | WO2006116349A3 Sustained release formulation and dosing schedules of leukotriene synthesis inhibitor for human therapy |
| 01/18/2007 | WO2006115895A3 Phenyl ethyne compounds |
| 01/18/2007 | WO2006114775A3 Treatment of insulin resistance syndrome |
| 01/18/2007 | WO2006113308A8 Method for treating inflammatory bowel disease (ibd) by an anti-cd20 antibody |
| 01/18/2007 | WO2006113140A3 Novel compounds useful for bradykinin b1 receptor antagonism |
| 01/18/2007 | WO2006112694A3 Nutritional supplement with colostrum and epa or dha or gla |
| 01/18/2007 | WO2006110447A3 Pyrimidine derivatives and their use in the treatment of cancer |
| 01/18/2007 | WO2006110157A3 Nucleoside phosphonate conjugates as anti hiv agents |
| 01/18/2007 | WO2006110155B1 Solid forms of linezolid and processes for preparation thereof |
| 01/18/2007 | WO2006108680A3 Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against protozoa and helminthes |
| 01/18/2007 | WO2006108678A3 New s-adenosyl-l-methionine analogs with extended activated groups for transfer by methyltransferases |
| 01/18/2007 | WO2006108008A3 A method and composition for nutritionally improving glucose control and insulin action |
| 01/18/2007 | WO2006107902A9 Use of spirostenols to treat mitochondrial disorders |
| 01/18/2007 | WO2006104751A3 Methods and compositions for modulating rho-mediated gene transcription |
| 01/18/2007 | WO2006102596A3 Dosage regimen for the treatment of a traumatic brain injury with progesterone |
| 01/18/2007 | WO2006102097A3 Synthesis of avrainvillamide, stephacidin b, and analogues thereof |
| 01/18/2007 | WO2006100635A3 Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists |
| 01/18/2007 | WO2006100263A3 Use of amides of sulfadimidine for the treatment of intestinal diseases in veterinary science |
| 01/18/2007 | WO2006099358A3 Antimicrobial compositions comprising esters of hydroxycarboxylic acids |
| 01/18/2007 | WO2006099217A3 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 01/18/2007 | WO2006096780A3 Sirtuin related therapeutics and diagnostics for neurodegenerative diseases |
| 01/18/2007 | WO2006096415A3 Modulation of neurodegenerative diseases through the estrogen receptor |
| 01/18/2007 | WO2006096168A3 Procedure for asthmatic, and other non-invasive surgery for brain tumor cures |
| 01/18/2007 | WO2006088748A3 Method for treating obesity |
| 01/18/2007 | WO2006087613A3 Stable oral benzimidazole compositions prepared by non-aqueous layering process |
| 01/18/2007 | WO2006086740A3 Cosmetic and cosmeceutical compositions for restoration of skin barrier function |
| 01/18/2007 | WO2006083930A3 Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 01/18/2007 | WO2006083491A3 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 01/18/2007 | WO2006076231A3 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 01/18/2007 | WO2006074166A3 Rnai agents for maintenance of stem cells |
| 01/18/2007 | WO2006072189A3 Spiro [bornyl - 2 , 4' - ( 1 , 3 -dioxanes) ] and their uses as fragrance ingredients |
| 01/18/2007 | WO2006068729A3 Methods and compositions for enhancing iron absorption |
| 01/18/2007 | WO2006066003A3 Methods and compositions for induction or promotion of immune tolerance |
| 01/18/2007 | WO2006061140A3 Composition of ssao substrates and metal compounds of the vla and vlb groups of the periodic table |
| 01/18/2007 | WO2006058869A8 Substituted pteridines for treating inflammatory diseases |
| 01/18/2007 | WO2006058868A8 Substituted pteridines for treating inflammatory diseases |
| 01/18/2007 | WO2006058294A3 Modulators of muscarinic receptors |
| 01/18/2007 | WO2006056607A8 Substituted pteridines for treating inflammatory diseases |
| 01/18/2007 | WO2006055951A3 Tetrahydroisoquinolines as factor xa inhibitors |
| 01/18/2007 | WO2006055875A3 Methods and compositions related to esculentoside a |
| 01/18/2007 | WO2006055526A3 Compositions useful to treat ocular neovascular diseases and macular degeneration |
| 01/18/2007 | WO2006053255A3 Novel betulin derivatives, preparation thereof and use thereof |
| 01/18/2007 | WO2006052790A3 Biodegradable linkers for molecular therapies |
| 01/18/2007 | WO2006042104A3 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 01/18/2007 | WO2006036926A3 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 01/18/2007 | WO2006022955A3 Topoisomerase inhibitors |
| 01/18/2007 | WO2006020291A3 Vitamin b12 compositions |
| 01/18/2007 | WO2006017443A3 Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds |
| 01/18/2007 | WO2006010967A8 Kynurenic acid amide derivatives as nr2b receptor antagonists |
| 01/18/2007 | WO2006007431A3 Catalyst solution dispenser for a spraying apparatus |
| 01/18/2007 | WO2005120638A8 Combination of radio waves and pharmacologically active substances |
| 01/18/2007 | WO2005107470A3 Use of carbonic anhydrase inhibitors for insect control and malaria treatment |
| 01/18/2007 | WO2005102329B1 An innovative screening method for coronary heart disease and stroke |
| 01/18/2007 | WO2005097192A9 Active substance combination of a carbinol compound and an opioid |
| 01/18/2007 | WO2005084307A3 Use of lipid conjugates in the treatment of disease |
| 01/18/2007 | WO2005079384A3 Expandable gastric retention device |
| 01/18/2007 | WO2005070893A3 Azadecalin glucocorticoid receptor modulators |
| 01/18/2007 | WO2005016272A3 Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders |
| 01/18/2007 | WO2005007112A3 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| 01/18/2007 | WO2004071468A3 Short immunomodulatory oligonucleotides |
| 01/18/2007 | WO2004042348A3 Methods for the identification of inhibitors of chitin synthase 2, s-adenosylmethionine decarboxylase, putrescine aminopropyltransferase, and methylenetetrahydrofolate reductase as antibiotics |
| 01/18/2007 | WO2004028441A8 Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof |
| 01/18/2007 | WO2003046207A3 Methods for inhibiting deacetylase activity |
| 01/18/2007 | US20070016982 Transgenic plants with increased titerpene saponin levels |
| 01/18/2007 | US20070016074 Contact lens for collecting tears and detecting analytes for determining health status, ovulation detection, and diabetes screening |
| 01/18/2007 | US20070015907 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 01/18/2007 | US20070015905 2'- and 3'-prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides, or their salts for treating hepatitis C virus infection; 3' or 4' O- substitution in furan ring containing at least one acyl or amino acid residue |
| 01/18/2007 | US20070015841 Pharmaceutical propylene glycol solvate compositions |
| 01/18/2007 | US20070015840 Use of an alkyl ether of hydroxystilbene for the treatment of dry skin |